{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:56:43Z","timestamp":1778864203959,"version":"3.51.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10067-020-05374-z","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T19:03:41Z","timestamp":1598987021000},"page":"1525-1531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The anti-inflammatory properties of HDLs are impaired in gout"],"prefix":"10.1007","volume":"40","author":[{"given":"Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,1]]},"reference":[{"issue":"10140","key":"5374_CR1","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1016\/S0140-6736(18)31366-7","volume":"391","author":"R Barnett","year":"2018","unstructured":"Barnett R (2018) Gout. Lancet 391(10140):2595","journal-title":"Lancet"},{"issue":"8","key":"5374_CR2","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","volume":"57","author":"M Bevis","year":"2018","unstructured":"Bevis M, Blagojevic-Bucknall M, Mallen C, Hider S, Roddy E (2018) Comorbidity clusters in people with gout: an observational cohort study with linked medical record review. Rheumatology (Oxford) 57(8):1358\u20131363","journal-title":"Rheumatology (Oxford)"},{"key":"5374_CR3","doi-asserted-by":"crossref","unstructured":"Hsu T-W, Lee P-S, Nfor ON, Lee C-L, Chen P-H, Tantoh DM, Lin L-Y, Chou M-C, Lee Y-C, Liaw Y-P (2019) The interaction between sex and hyperlipidemia on gout risk is modulated by HLA-B polymorphic variants in adult Taiwanese. Genes (Basel) 10(3)","DOI":"10.3390\/genes10030246"},{"issue":"4","key":"5374_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0049-0172(78)90024-0","volume":"7","author":"TF Y\u00fc","year":"1978","unstructured":"Y\u00fc TF, Dorph DJ, Smith H (1978) Hyperlipidemia in primary gout. Semin Arthritis Rheum 7(4):233\u2013244","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"5374_CR5","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3899\/jrheum.170806","volume":"45","author":"MM Elfishawi","year":"2018","unstructured":"Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ, Crowson CS, Matteson EL, Bongartz T (2018) The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. J Rheumatol 45(4):574\u2013579","journal-title":"J Rheumatol"},{"issue":"Suppl","key":"5374_CR6","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1194\/jlr.R800097-JLR200","volume":"50","author":"JW Heinecke","year":"2009","unstructured":"Heinecke JW (2009) The HDL proteome: a marker--and perhaps mediator--of coronary artery disease. J Lipid Res 50(Suppl):S167\u2013S171","journal-title":"J Lipid Res"},{"issue":"4","key":"5374_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ed.ed_22_19","volume":"4","author":"Y Wang","year":"2019","unstructured":"Wang Y, Wang Z, Li X, Zhang B (2019) Correlation between serum apolipoprotein A1 and serum uric acid level in patients with hyperuricemia. Environ Dis 4(4):95\u201398","journal-title":"Environ Dis"},{"issue":"10","key":"5374_CR8","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","volume":"124","author":"M Ouimet","year":"2019","unstructured":"Ouimet M, Barrett TJ, Fisher EA (2019) HDL and reverse cholesterol transport. Circ Res 124(10):1505\u20131518","journal-title":"Circ Res"},{"issue":"13","key":"5374_CR9","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2174\/138161210791051022","volume":"16","author":"I Meurs","year":"2010","unstructured":"Meurs I, Van Eck M, Van Berkel TJC (2010) High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis. Curr Pharm Des 16(13):1445\u20131467","journal-title":"Curr Pharm Des"},{"issue":"11","key":"5374_CR10","first-page":"639","volume":"13","author":"AK So","year":"2017","unstructured":"So AK, Martinon F (2017) Inflammation in gout: mechanisms and therapeutic targets. Nature reviews. Rheumatology 13(11):639\u2013647","journal-title":"Rheumatology"},{"issue":"34","key":"5374_CR11","doi-asserted-by":"publisher","first-page":"13257","DOI":"10.1074\/jbc.RA118.002428","volume":"293","author":"P Shridas","year":"2018","unstructured":"Shridas P, De Beer MC, Webb NR (2018) High-density lipoprotein inhibits serum amyloid A-mediated reactive oxygen species generation and NLRP3 inflammasome activation. J Biol Chem 293(34):13257\u201313269","journal-title":"J Biol Chem"},{"issue":"3","key":"5374_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/imm.12638","volume":"149","author":"SG Thacker","year":"2016","unstructured":"Thacker SG, Zarzour A, Chen Y, Alcicek MS, Freeman LA, Sviridov DO, Demosky SJ, Remaley AT (2016) High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation. Immunology 149(3):306\u2013319","journal-title":"Immunology"},{"issue":"3","key":"5374_CR13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/annrheumdis-2013-203803","volume":"74","author":"A Scanu","year":"2015","unstructured":"Scanu A, Luisetto R, Oliviero F, Gruaz L, Sfriso P, Burger D, Punzi L (2015) High-density lipoproteins inhibit urate crystal-induced inflammation in mice. Ann Rheum Dis 74(3):587\u2013594","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"5374_CR14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.2215\/CJN.04360418","volume":"14","author":"AM Hung","year":"2019","unstructured":"Hung AM, Tsuchida Y, Nowak KL, Sarkar S, Chonchol M, Whitfield V, Salas N, Dikalova A, Yancey PG, Huang J, Linton MRF, Ikizler TA, Kon V (2019) IL-1 inhibition and function of the HDL-containing fraction of plasma in patients with stages 3 to 5 CKD. Clin J Am Soc Nephrol 14(5):702\u2013711","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"5374_CR15","doi-asserted-by":"publisher","first-page":"R563","DOI":"10.1186\/ar1443","volume":"6","author":"B Bresnihan","year":"2004","unstructured":"Bresnihan B, Gogarty M, FitzGerald O, Dayer J-M, Burger D (2004) Apolipoprotein A-I infiltration in rheumatoid arthritis synovial tissue: a control mechanism of cytokine production? Arthritis Res Ther 6(6):R563\u2013R566","journal-title":"Arthritis Res Ther"},{"key":"5374_CR16","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1155\/2016\/1028401","volume":"2016","author":"L Duan","year":"2016","unstructured":"Duan L, Huang Y, Qun S, Lin Q, Liu W, Luo J, Yu B, He Y, Qian H, Liu Y, Chen J, Shi G (2016) Potential of IL-33 for preventing the kidney injury via regulating the lipid metabolism in gout patients. J Diabetes Res 2016:102\u2013401","journal-title":"J Diabetes Res"},{"issue":"1","key":"5374_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/abbi.1999.1387","volume":"370","author":"BS Kristal","year":"1999","unstructured":"Kristal BS, Vigneau-Callahan KE, Moskowitz AJ, Matson WR (1999) Purine catabolism: links to mitochondrial respiration and antioxidant defenses? Arch Biochem Biophys 370(1):22\u201333","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"5374_CR18","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbalip.2016.03.004","volume":"1861","author":"M Lee-Rueckert","year":"2016","unstructured":"Lee-Rueckert M, Escola-Gil JC, Kovanen PT (2016) HDL functionality in reverse cholesterol transport - challenges in translating data emerging from mouse models to human disease. Biochim Biophys Acta 1861(7):566\u2013583","journal-title":"Biochim Biophys Acta"},{"key":"5374_CR19","doi-asserted-by":"crossref","unstructured":"Tseng C-C, Chen C-J, Yen J-H, Huang H-Y, Chang J-G, Chang S-J, Liao W-T (2018) Next-generation sequencing profiling of mitochondrial genomes in gout. Arthritis Res Ther 20(1):137","DOI":"10.1186\/s13075-018-1637-5"},{"key":"5374_CR20","doi-asserted-by":"crossref","unstructured":"Cardona F, Tinahones FJ, Collantes E, Escudero A, Garc\u00eda-Fuentes E, Soriguer FJ (2005) Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout. Ann Rheum Dis 64(1):85-88","DOI":"10.1136\/ard.2003.019695"},{"issue":"6","key":"5374_CR21","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1161\/CIRCRESAHA.116.309506","volume":"119","author":"S Fazio","year":"2016","unstructured":"Fazio S, Pamir N (2016) HDL particle size and functional heterogeneity. Circ Res 119(6):704\u2013707","journal-title":"Circ Res"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05374-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05374-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05374-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T02:28:05Z","timestamp":1630463285000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05374-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,1]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["5374"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05374-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,1]]},"assertion":[{"value":"5 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}